Cetilistat

赛利司他

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCetilistat
Drug Alias Name新利司他Cetilistatum西替司他Cametor西替利斯塔 +[10
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGastric lipase inhibitors
TargetsGastric lipase
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2
Global Approved IndicationsObesity
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2013/09/20
Country/TerritoryUnited StatesSwedenNetherlands +[7
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesNorgine Europe Bv
China Registration ClassN/A

Develop Information

Inactive CompaniesAlizyme
Active IndicationsObesity
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeA08A
Related LinksWikipediaKEGG